General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Danone(SIGNIFICANT), Acasti Pharma, Inc.(SIGNIFICANT), Barilla, Motif FoodWorks(MODEST), Cleveland Clinic Foundation(MODEST), America’s Test Kitchen(MODEST), Amarin(MODEST), GOED(MODEST), Nutrition Impact(MODEST), Bunge(MODEST), Indigo Agriculture(MODEST) EQUITY INTERESTS/STOCK OPTIONS: Calibrate and HumanCo(SIGNIFICANT) OWNERSHIP/PARTNERSHIP/PRINCIPAL: UpToDate, royalties for online chapters(MODEST) RESEARCH/RESEARCH GRANTS: National Institutes of Health(SIGNIFICANT), The Rockefeller Foundation(SIGNIFICANT), Gates Foundation(SIGNIFICANT), Vail Innovative Global Research(SIGNIFICANT), Kaiser Permanente Fund at East Bay Community Foundation(SIGNIFICANT) OTHER FINANCIAL BENEFIT: Beren Therapeutics, Brightseed, Calibrate, Discern Dx, Elysium Health, Filtricine, HumanCo, Instacart, January Inc., Perfect Day, Tiny Organics, and (ended) Day Two and Season Health(SIGNIFICANT)

View Full Disclosure